Endothelial dysfunction and inflammation in asymptomatic proteinuria

被引:96
作者
Paisley, KE
Beaman, M
Tooke, JE
Mohamed-Ali, V
Lowe, GDO
Shore, AC
机构
[1] Royal Devon & Exeter Hosp, Inst Biomed & Clin Sci, Peninsula Med Sch, Exeter EX2 5DW, Devon, England
[2] Royal Devon & Exeter Hosp, Renal Unit, Exeter EX2 5DW, Devon, England
[3] UCL, Dept Med, London, England
[4] Univ Glasgow, Dept Med, Glasgow, Lanark, Scotland
关键词
endothelial function; iontophoresis; brachial artery ultrasound; inflammation; C-reactive protein; von Willebrand factor; proteinuria;
D O I
10.1046/j.1523-1755.2003.00768.x
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Background. Proteinuria is associated with vascular risk and a systemic increase in vascular permeability. Endothelial dysfunction occurs early in atherosclerosis and modulates vascular permeability. Vascular risk and chronic inflammation are associated. This study investigates whether the increased vascular permeability in proteinuria reflects systemic endothelial dysfunction and chronic inflammation. Methods. Twenty-one patients with asymptomatic proteinuria (1.29 g/24 h; range 0.18 to 3.17) and 21 matched controls were studied. Microvascular endothelial function was assessed using acetylcholine iontophoresis. Maximum microvascular hyperemia (MMH) was assessed by flux response to local skin heating. Macrovascular endothelial function was assessed by flow-associated dilation (FAD) in the brachial artery using ultrasound. von Willebrand factor (vWF) was measured as a marker of endothelial activation. Low-grade inflammation was assessed by measurement of circulating C-reactive protein (CRP) values using a high sensitivity assay. Results. FAD was impaired in proteinuric subjects (AP) compared to controls [1.8 (0.2 to 5.3) AP vs. 3.8 (1.5 to 6.2) C %; P = 0.014]. There was no significant difference between groups in MMH or in the response to acetylcholine iontophoresis. The AP group had a higher CRP [4.0 (0.5 to 39.0) AP vs. 0.2 (0.1 to 21.3) C mg/L; P < 0.001] and tendency to higher vWF [101.5 (67.0 to 197.0) AP vs. 77.5 (45.0 to 185.0) C IU/dL; P = 0.046] compared to controls. In the AP, but not control, group there was an inverse correlation between CRP and microvascular function as determined by acetylcholine iontophoresis (r = -0.509; P = 0.018). Conclusions. In AP subjects there is evidence of macrovascular endothelial dysfunction remote from the kidney and of low-grade inflammation that is associated with microvascular endothelial dysfunction.
引用
收藏
页码:624 / 633
页数:10
相关论文
共 68 条
[1]  
Adams M., 1996, Journal of Vascular Investigation, V2, P146
[2]   Detection of presymptomatic atherosclerosis: a current perspective [J].
Adams, MR ;
Celermajer, DS .
CLINICAL SCIENCE, 1999, 97 (05) :615-624
[3]   Elevated levels of interleukin-6 in unstable angina [J].
Biasucci, LM ;
Vitelli, A ;
Liuzzo, G ;
Altamura, S ;
Caligiuri, G ;
Monaco, C ;
Rebuzzi, AG ;
Ciliberto, G ;
Maseri, A .
CIRCULATION, 1996, 94 (05) :874-877
[4]   Cytoskeletal rearrangement mediates human microvascular endothelial tight junction modulation by cytokines [J].
Blum, MS ;
Toninelli, E ;
Anderson, JM ;
Balda, MS ;
Zhou, JY ;
O'Donnell, L ;
Pardi, R ;
Bender, JR .
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 1997, 273 (01) :H286-H294
[5]   IMPAIRED ENDOTHELIUM-DEPENDENT VASCULAR RELAXATION IN PATIENTS WITH HYPERCHOLESTEROLEMIA EXTENDS BEYOND THE MUSCARINIC RECEPTOR [J].
CASINO, PR ;
KILCOYNE, CM ;
CANNON, RO ;
QUYYUMI, AA ;
PANZA, JA .
AMERICAN JOURNAL OF CARDIOLOGY, 1995, 75 (01) :40-44
[6]   NONINVASIVE DETECTION OF ENDOTHELIAL DYSFUNCTION IN CHILDREN AND ADULTS AT RISK OF ATHEROSCLEROSIS [J].
CELERMAJER, DS ;
SORENSEN, KE ;
GOOCH, VM ;
SPIEGELHALTER, DJ ;
MILLER, OI ;
SULLIVAN, ID ;
LLOYD, JK ;
DEANFIELD, JE .
LANCET, 1992, 340 (8828) :1111-1115
[7]  
CHAUVEAU M, 1985, CARDIOVASC RES, V19, P700, DOI 10.1093/cvr/19.11.700
[8]  
Clausen P, 2001, CIRCULATION, V103, P1869
[9]   Endothelial dysfunction as a possible link between C-reactive protein levels and cardiovascular disease [J].
Cleland, SJ ;
Sattar, N ;
Petrie, JR ;
Forouhi, NG ;
Elliott, HL ;
Connell, JMC .
CLINICAL SCIENCE, 2000, 98 (05) :531-535
[10]   IS NO AN ENDOGENOUS ANTIATHEROGENIC MOLECULE [J].
COOKE, JP ;
TSAO, PS .
ARTERIOSCLEROSIS AND THROMBOSIS, 1994, 14 (05) :653-655